Primary antibodies, anti-Ki 67 (#sc23900, Santa Cruz Biotechnology, USA) and anti-phospho IRE1 alpha (p-IRE1) (#AF7150, Affinity Biosciences, USA) were applied at a 1:100 dilution for 3 h at RT
Peptides: Tesamorelin, AOD9604, Tirzepatide (GLP-1 agonist) Tesamorelin is FDA-approved to reduce visceral adipose tissue (VAT) in HIV-associated lipodystrophy, but its fat-burning effects also appear in non-HIV populations AOD9604 is a modified fragment of human GH (176191) shown in animal and early human trials to enhance lipolysis without altering blood sugar or cortisol Tirzepatide , while technically a GLP-1/GIP agonist , is now frequently stacked with peptides in clinical practice to accelerate fat loss and appetite control
Following physically demanding activities or adventures
Oil Wash: Glycerin, Aqua, Cocamidopropyl Betaine, Disodium Cocoamphodiacetate, Hippophae Rhamnoides Fruit/Seed Oil, Rosa Canina (Rose Hips) Fruit Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Squalane, Pyrus Malus (Apple) Fruit Extract, Polyquaternium-10, Maltodextrin, Sorbitan Oleate Decylglucoside Crosspolymer, Phenoxyethanol, Cocos Nucifera (Coconut) Fruit Extract, Vanilla Planifolia Fruit Extract, Gardenia Jasminoides Fruit Extract, Eugenia Caryophyllus (Clove) Flower Extract, Prunus Armeniaca (Apricot) Fruit Extract, Prunus Persica (Peach) Fruit Extract, Citric Acid, Ethylhexylglycerin, Tetrasodium Glutamate Diacetate
in the first days of treatment
YW: Supervision, Data curation, Writing review & editing
